ADD3 and chronic obstructive pulmonary disease: Furthermore, survival analysis using the Kaplan–Meier method revealed no statistically significant difference in OS between high and low expressions of ADD3 and GNAS in the COPD samples from the validation cohort, with p‐values of 0.448 (Figure 11A) and 0.703 (Figure 11B), respectively.